Literature DB >> 33707563

Presence of tophi is associated with a rapid decline in the renal function in patients with gout.

Yoon-Jeong Oh1, Ki Won Moon2.   

Abstract

We aimed to compare clinical characteristics of patients with and without tophi at the time of the diagnosis of gout and investigate the association of tophi and renal function in gout patients. The patients who were first diagnosed with gout at the Kangwon National University Hospital were retrospectively studied. Patients were divided into 2 groups according to the presence of tophi at the diagnosis. We compared clinical characteristics and the progression of renal dysfunction between the two groups. Of 276 patients, 66 (25.5%) initially presented with tophi. Tophi group was older, had a longer symptom duration, and a higher prevalence of multiple joint involvement than those without tophi. In multivariate logistic regression analysis, prolonged symptom duration and multiple joint involvement were significantly associated with increased risk of formation of tophi. The decline in the eGFR was more prominent in patients with tophi than in those without (- 4.8 ± 14.5 vs. - 0.7 ± 11.9 ml/min/1.73 m2/year, respectively; P = 0.039). The presence of tophi was significantly associated with a rapid decline in the eGFR (β = - 0.136; P = 0.042). In conclusion, the presence of tophi was associated with a rapid declining renal function. Therefore, an early diagnosis and closely monitoring of renal function might be important in gout patients with tophi.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33707563      PMCID: PMC7952381          DOI: 10.1038/s41598-021-84980-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  27 in total

Review 1.  Acute nephrotoxicity of NSAID from the foetus to the adult.

Authors:  M Musu; G Finco; R Antonucci; E Polati; D Sanna; M Evangelista; D Ribuffo; V Schweiger; V Fanos
Journal:  Eur Rev Med Pharmacol Sci       Date:  2011-12       Impact factor: 3.507

Review 2.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

Review 3.  Comorbidities in gout and hyperuricemia: causality or epiphenomena?

Authors:  Nicholas A Sumpter; Kenneth G Saag; Richard J Reynolds; Tony R Merriman
Journal:  Curr Opin Rheumatol       Date:  2020-03       Impact factor: 5.006

Review 4.  Definition of hyperuricemia and gouty conditions.

Authors:  Thomas Bardin; Pascal Richette
Journal:  Curr Opin Rheumatol       Date:  2014-03       Impact factor: 5.006

Review 5.  Chronic tophaceous gout as the first manifestation of gout in two cases and a review of the literature.

Authors:  Amir Bieber; Naomi Schlesinger; Abdallah Fawaz; Reuven Mader
Journal:  Semin Arthritis Rheum       Date:  2017-11-27       Impact factor: 5.532

6.  Management of Gout and Hyperuricemia in CKD.

Authors:  Ana Beatriz Vargas-Santos; Tuhina Neogi
Journal:  Am J Kidney Dis       Date:  2017-04-26       Impact factor: 8.860

Review 7.  Gout.

Authors:  Nicola Dalbeth; Tony R Merriman; Lisa K Stamp
Journal:  Lancet       Date:  2016-04-21       Impact factor: 79.321

8.  2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Tuhina Neogi; Tim L Th A Jansen; Nicola Dalbeth; Jaap Fransen; H Ralph Schumacher; Dianne Berendsen; Melanie Brown; Hyon Choi; N Lawrence Edwards; Hein J E M Janssens; Frédéric Lioté; Raymond P Naden; George Nuki; Alexis Ogdie; Fernando Perez-Ruiz; Kenneth Saag; Jasvinder A Singh; John S Sundy; Anne-Kathrin Tausche; Janitzia Vaquez-Mellado; Steven A Yarows; William J Taylor
Journal:  Ann Rheum Dis       Date:  2015-10       Impact factor: 19.103

9.  Association of Specific Comorbidities with Monosodium Urate Crystal Deposition in Urate-Lowering Therapy-Naive Gout Patients: A Cross-Sectional Dual-Energy Computed Tomography Study.

Authors:  Tristan Pascart; André Ramon; Sébastien Ottaviani; Julie Legrand; Vincent Ducoulombier; Eric Houvenagel; Laurène Norberciak; Pascal Richette; Fabio Becce; Paul Ornetti; Jean-François Budzik
Journal:  J Clin Med       Date:  2020-05-01       Impact factor: 4.241

10.  Hyperuricemia and its association with adiposity and dyslipidemia in Northwest China: results from cardiovascular risk survey in Xinjiang (CRS 2008-2012).

Authors:  Fen Liu; Guo-Li Du; Ning Song; Yi-Tong Ma; Xiao-Mei Li; Xiao-Ming Gao; Yi-Ning Yang
Journal:  Lipids Health Dis       Date:  2020-04-01       Impact factor: 3.876

View more
  2 in total

1.  Analysis of Risk Factors for Changes in the Renal Two-Dimensional Image in Gout Patients.

Authors:  Wantai Dang; Xiaohui Xu; Danling Luo; Hui Luo; Jin Hu; Jingguo Zhou; Jian Liu; Lanlan You
Journal:  Int J Gen Med       Date:  2021-10-05

Review 2.  Research progress of risk factors and early diagnostic biomarkers of gout-induced renal injury.

Authors:  Sheng Wang; Liyun Zhang; Dongsheng Hao; Lei Wang; Jiaxi Liu; Qing Niu; Liangyu Mi; Xinyue Peng; Jinfang Gao
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.